Gene: UTS2

10911
PRO1068|U-II|UCN2|UII
urotensin 2
protein-coding
1p36.23
Ensembl:ENSG00000049247 MIM:604097 Vega:OTTHUMG00000001218 UniprotKB:O95399
NC_000001.11
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
8.251e-1 (AD)  5.616e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
NTS0.771
FOXB10.766
SIM10.761
LHX50.759
OTP0.758
HMX20.757
DAPL10.744
C22orf420.743
SIX60.743
SOX140.739

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SHANK3-0.401
LZTS1-0.39
MGAT5B-0.366
PITPNM2-0.364
CRTC1-0.364
TNRC18-0.361
CYTH3-0.36
DDN-0.357
ICAM5-0.354
ELFN2-0.35

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA"25510870
D000082AcetaminophenAcetaminophen affects the expression of UTS2 mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in increased methylation of UTS2 gene27153756
D000638AmiodaroneAmiodarone results in increased expression of UTS2 mRNA19774075
D000643Ammonium ChlorideAmmonium Chloride affects the expression of UTS2 mRNA16483693
D000968Antimycin AAntimycin A results in increased expression of UTS2 mRNA19304788
D004958EstradiolEstradiol results in increased expression of UTS2 mRNA19484750
C006780bisphenol Abisphenol A results in decreased expression of UTS2 mRNA25181051
D0151248-Bromo Cyclic Adenosine Monophosphate8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UTS2 mRNA22079614
C018475butyraldehydebutyraldehyde results in increased expression of UTS2 mRNA26079696
D019256Cadmium ChlorideCadmium Chloride affects the expression of UTS2 mRNA23828170
C089595cylindrospermopsincylindrospermopsin results in decreased expression of UTS2 mRNA24921660
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of UTS2 mRNA21056072
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of UTS2 protein21056072
C074283estradiol 3-benzoateestradiol 3-benzoate results in increased methylation of UTS2 promoter27415467
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of UTS2 mRNA20044591
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of UTS2 mRNA23086925
D008727MethotrexateMethotrexate affects the expression of UTS2 mRNA18502557
C119536nickel acetatenickel acetate affects the expression of UTS2 mRNA23828170
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UTS2 mRNA"25510870
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of UTS2 mRNA19710929
D059808PolyphenolsPolyphenols results in decreased expression of UTS2 mRNA16293270
D011441PropylthiouracilPropylthiouracil results in decreased expression of UTS2 mRNA24780913
D012402RotenoneRotenone results in increased expression of UTS2 mRNA19304788
D012822Silicon DioxideSilicon Dioxide analog results in increased expression of UTS2 mRNA23806026
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of UTS2 mRNA21998131
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of UTS2 gene25560391

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005102signaling receptor binding-TAS10499587  
GO:0005179hormone activity-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006936muscle contraction-TAS10499587  
GO:0007186G-protein coupled receptor signaling pathway-TAS-  
GO:0007268chemical synaptic transmission-TAS10499587  
GO:0008217regulation of blood pressure-IBA21873635  
GO:0008217regulation of blood pressure-IEA-  
GO:0010469regulation of signaling receptor activity-IEA-  
GO:0097746regulation of blood vessel diameter-IBA21873635  
GO:0097746regulation of blood vessel diameter-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-TAS-  
GO:0005615extracellular space-IBA21873635  
GO:0005615extracellular space-TAS10499587  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-162582Signal TransductionTAS
R-HSA-372790Signaling by GPCRTAS
R-HSA-373076Class A/1 (Rhodopsin-like receptors)TAS
R-HSA-375276Peptide ligand-binding receptorsTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-416476G alpha (q) signalling eventsTAS
R-HSA-500792GPCR ligand bindingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
18338983Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. (2008 Dec)Suguro TClin Sci (Lond)